- Home
- TRVI vs SKBL Comparison
TRVI vs SKBL Comparison
Compare TRVI & SKBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- SKBL
- Stock Information
- Founded
- TRVI 2011
- SKBL 2012
- Country
- TRVI United States
- SKBL Hong Kong
- Employees
- TRVI N/A
- SKBL N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- SKBL
- Sector
- TRVI Health Care
- SKBL
- Exchange
- TRVI Nasdaq
- SKBL NYSE
- Market Cap
- TRVI 383.4M
- SKBL 389.6M
- IPO Year
- TRVI 2019
- SKBL 2025
- Fundamental
- Price
- TRVI $6.61
- SKBL $12.35
- Analyst Decision
- TRVI Strong Buy
- SKBL
- Analyst Count
- TRVI 8
- SKBL 0
- Target Price
- TRVI $17.56
- SKBL N/A
- AVG Volume (30 Days)
- TRVI 1.3M
- SKBL 745.6K
- Earning Date
- TRVI 05-08-2025
- SKBL 01-01-0001
- Dividend Yield
- TRVI N/A
- SKBL N/A
- EPS Growth
- TRVI N/A
- SKBL N/A
- EPS
- TRVI N/A
- SKBL 0.03
- Revenue
- TRVI N/A
- SKBL $49,638,709.00
- Revenue This Year
- TRVI N/A
- SKBL N/A
- Revenue Next Year
- TRVI N/A
- SKBL N/A
- P/E Ratio
- TRVI N/A
- SKBL $393.54
- Revenue Growth
- TRVI N/A
- SKBL 9.58
- 52 Week Low
- TRVI $2.30
- SKBL $6.93
- 52 Week High
- TRVI $7.39
- SKBL $13.50
- Technical
- Relative Strength Index (RSI)
- TRVI 56.38
- SKBL N/A
- Support Level
- TRVI $6.37
- SKBL N/A
- Resistance Level
- TRVI $7.24
- SKBL N/A
- Average True Range (ATR)
- TRVI 0.42
- SKBL 0.00
- MACD
- TRVI -0.01
- SKBL 0.00
- Stochastic Oscillator
- TRVI 50.38
- SKBL 0.00
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About SKBL SKYLINE BUILDERS GROUP HOLDING LIMI
Skyline Builders Group Holding Ltd is an holding company operates through its subsidiary. It is a Public Works Contractor company undertaking roads and drainage in Hong Kong. Its construction activities mainly include public civil engineering works, such as road and drainage works, in Hong Kong.